Biotech VC Dimension Launches $500M Second Fund

Venture capital firm Dimension Capital announced the launch of its second fund targeting startups at the intersection of life sciences and technology, seeking to raise $500M for the new fund.

Dimension Capital II aims to continue on the success of the firm’s oversubscribed $350M first fund, which capitalized on emerging investor interest in the life sciences sector. For Dimension II, the firm has expanded its remit to include robotics companies, machine-learning-focused firms, and early stage and wholly-owned clinical trials.

Since its inception in 2022, the firm has invested in 28 biotech companies, including Chai Discovery, a startup building an open-source AI model for drug discovery, and Enverda Biosciences, a biotech company leveraging AI to discover new medicines from natural compounds.

New call-to-action

Written By: Dakota

logo-1

The Database For Cold Outreach to Reach Institutional and RIA Investors